Apex Biotechnology Corp represents values of innovation, integrity, and excellence in the biotechnology industry. Committed to advancing scientific discovery and improving global healthcare, Apex Biotechnology Corp is dedicated to researching, developing, and commercializing novel therapies and precision medicine solutions. With a strong emphasis on collaboration and partnerships, the company aims to revolutionize the treatment of diseases and enhance patients' lives. By adopting cutting-edge technologies and leveraging its expertise, Apex Biotechnology Corp strives to address unmet medical needs and make a positive impact on society.

Apex Biotechnology Corp is primarily present in multiple countries and regions worldwide. As a global company, Apex Biotechnology Corp has established its presence in key markets such as the United States, Europe, Asia Pacific, and Latin America. With a strong focus on expanding its international footprint, the company has strategically invested in subsidiaries and partnerships to effectively serve customers across these regions. Apex Biotechnology Corp's global presence enables it to leverage diverse market opportunities, foster collaborations, and deliver innovative solutions to its customers in the biotechnology sector.

Apex Biotechnology Corp has achieved several significant milestones. The company successfully developed and launched innovative biotech products, leading to a strong market presence. Additionally, Apex Biotechnology Corp received multiple prestigious awards, acknowledging its dedication to excellence in research and development. The company's commitment to cutting-edge technologies has enabled it to establish collaborations with renowned institutions, further enhancing its expertise and capabilities. Apex Biotechnology Corp's growth and success are evident in their expanding global market share and increasing profitability.

Apex Biotechnology Corp is a leading biotechnology company with a rich history and background. It was founded in [year] and has since positioned itself as a key player in the biotech industry. With a strong focus on innovation and research, Apex Biotechnology Corp has made significant contributions to the advancement of healthcare globally. The company is known for its cutting-edge technologies and breakthrough discoveries in the field of biopharmaceuticals. Through strategic collaborations and partnerships, Apex Biotechnology Corp continues to drive growth and create value for its stakeholders. This commitment to excellence has earned Apex Biotechnology Corp a reputable name in the market.

The main competitors of Apex Biotechnology Corp in the market include XYZ Pharmaceuticals, ABC Biosciences, and LMN Healthcare. These companies are also engaged in the biotechnology industry and offer similar products and services as Apex Biotechnology Corp. However, Apex Biotechnology Corp has garnered a strong reputation and competitive advantage through its innovative approach, cutting-edge research, and consistent product quality, setting it apart from its competitors in the market.

Apex Biotechnology Corp is primarily active in the biotechnology industry.

The business model of Apex Biotechnology Corp revolves around developing and commercializing innovative biotechnology solutions. As a company, Apex focuses on researching, developing, and manufacturing advanced biopharmaceutical products. They aim to address unmet medical needs and improve patients' quality of life through their cutting-edge technologies. Apex Biotechnology Corp strives to create value by leveraging their expertise in biotechnology research, development, and manufacturing to bring safe and effective therapeutic treatments to the market. With a strong commitment to innovation, Apex Biotechnology Corp aims to contribute to the advancement of the biotechnology industry while enhancing shareholder value.

Apex Biotechnology의 P/E 비율은 26.34입니다.

Apex Biotechnology의 P/S 비율은 1.46입니다.

Apex Biotechnology에 대한 AlleAktien 품질 점수는 4/10입니다.

예상되는 Apex Biotechnology 매출은 1.93 조. TWD입니다.

예상되는 Apex Biotechnology 이익은 107.05 백만 TWD입니다.

Apex Biotechnology Corp is a leading provider of innovative products and services in the field of biotechnological research. The company is divided into several business areas, including research and development services, production and distribution of biotechnological products, as well as diagnostic and analysis tools.

Apex Biotechnology은(는) 연간 번의 배당을 통해 1.3 TWD의 배당금을 지급합니다.

Apex Biotechnology의 현재 배당금은 계산할 수 없거나, 회사가 배당금을 지급하지 않습니다.

Apex Biotechnology의 ISIN은 TW0001733004입니다.

Apex Biotechnology의 티커는 1733.TW입니다.

지난 12개월 동안 Apex Biotechnology은(는) 1.4 TWD 의 배당금을 지급했습니다. 이는 약 4.98 %의 배당 수익률에 해당합니다. 향후 12개월 동안 Apex Biotechnology은(는) 1.4 TWD의 배당금을 지급할 것으로 예상됩니다.

Apex Biotechnology의 현재 배당 수익률은 4.98 %입니다.

Apex Biotechnology은 분기별로 배당금을 지급합니다. 이는 , , , 월에 배당됩니다.

Apex Biotechnology은(는) 지난 21년 동안 매년 배당금을 지급했습니다.

향후 12개월 동안 1.4 TWD의 배당금이 예상됩니다. 이는 배당수익률 4.98 %에 해당합니다.

Apex Biotechnology은 '건강' 섹터에 속합니다.

Apex Biotechnology의 마지막 배당금을 1.1 TWD만큼 받기 위해선 의 Ex-Tag 전에 주식을 보유하고 있어야 했습니다.

마지막 배당금 지급일은 입니다.

2023년에 Apex Biotechnology는 1.3 TWD를 배당금으로 지급했습니다.

Apex Biotechnology의 배당금은 TWD에 지급됩니다.